Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme (Q28205919)

From Wikidata
Jump to navigation Jump to search
scientific article (publication date: May 2002)
edit
Language Label Description Also known as
English
Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme
scientific article (publication date: May 2002)

    Statements

    Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme (English)
    0 references
    0 references
    0 references
    M Campone
    0 references
    B Coudert
    0 references
    M Van den Bent
    0 references
    M de Jonge
    0 references
    C Dittrich
    0 references
    R Rampling
    0 references
    R Sorio
    0 references
    D Lacombe
    0 references
    C de Balincourt
    0 references
    P Fumoleau
    0 references
    May 2002
    0 references
    13
    0 references
    5
    0 references
    777-80
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit